Product Code: ETC13272912 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global End Stage Renal Disease Market was valued at USD 96.4 Billion in 2024 and is expected to reach USD 134.7 Billion by 2031, growing at a compound annual growth rate of 7.00% during the forecast period (2025-2031).
The global End Stage Renal Disease (ESRD) market is characterized by an increasing prevalence of chronic kidney diseases leading to ESRD, coupled with a rising demand for renal replacement therapies such as dialysis and kidney transplantation. Technological advancements in hemodialysis and peritoneal dialysis machines, along with the development of innovative drugs for the management of ESRD, are driving market growth. The market is also witnessing a trend towards home-based dialysis treatments, offering increased convenience and flexibility to patients. Key players in the ESRD market are investing in research and development activities to introduce novel therapies and improve patient outcomes. Geographically, North America dominates the market due to a higher prevalence of ESRD, followed by Europe and the Asia Pacific regions. The market is expected to continue growing as the global burden of kidney diseases rises.
The Global End Stage Renal Disease (ESRD) market is witnessing several key trends and opportunities. One significant trend is the increasing prevalence of ESRD due to rising incidences of chronic conditions such as diabetes and hypertension. This has led to a growing demand for renal replacement therapies, including dialysis and kidney transplantation. Another trend is the shift towards home-based dialysis solutions, driven by the convenience and cost-effectiveness they offer to patients. Additionally, technological advancements such as wearable dialysis devices and artificial kidneys are opening up new opportunities in the market. Companies focusing on product innovation, expanding their geographical presence, and strategic collaborations with healthcare providers are well-positioned to capitalize on the growing ESRD market.
The Global End Stage Renal Disease (ESRD) Market faces several challenges, including limited access to dialysis treatment in developing countries, high treatment costs, and a shortage of donor kidneys for transplantation. The increasing prevalence of risk factors such as diabetes and hypertension leading to ESRD further strains healthcare systems globally. Additionally, the complexity of managing ESRD patients with multiple comorbidities and the need for long-term care present logistical and financial challenges for both patients and healthcare providers. Regulatory hurdles, reimbursement issues, and the need for continuous technological advancements in dialysis and transplant procedures also pose significant challenges in the ESRD market, impacting patient outcomes and quality of life. Addressing these challenges requires collaboration among stakeholders to improve access to care, enhance treatment affordability, and advance research in ESRD management.
The Global End Stage Renal Disease (ESRD) market is primarily driven by the increasing prevalence of chronic kidney diseases worldwide, leading to a growing number of patients requiring renal replacement therapy such as dialysis or kidney transplantation. Advancements in medical technology and treatments for ESRD, including the development of innovative dialysis techniques and immunosuppressive drugs, are also significant factors driving market growth. Additionally, the rising geriatric population, lifestyle changes leading to higher incidence of diabetes and hypertension, as well as increasing awareness about kidney health and early detection of renal diseases, are contributing to the expansion of the ESRD market. Moreover, favorable government initiatives and healthcare reimbursement policies further support the market by improving access to ESRD treatments and increasing affordability for patients.
Government policies related to the Global End Stage Renal Disease (ESRD) Market typically focus on improving access to renal replacement therapy, such as dialysis and kidney transplantation, for patients with ESRD. These policies often include reimbursement mechanisms to cover the high costs of treatment, regulatory frameworks to ensure quality of care, and initiatives to promote early detection and prevention of kidney disease. Additionally, government agencies may implement programs to educate healthcare providers and the public about ESRD management and prevention. Overall, the goal of these policies is to enhance the quality of life for ESRD patients, reduce healthcare costs associated with the disease, and address the growing burden of kidney disease on healthcare systems worldwide.
The Global End Stage Renal Disease (ESRD) market is poised for steady growth in the coming years due to the increasing prevalence of chronic kidney disease, aging population, and lifestyle factors such as obesity and diabetes. Technological advancements in renal replacement therapies, such as hemodialysis, peritoneal dialysis, and kidney transplantation, are expected to drive market expansion. Additionally, the rising awareness regarding early detection and treatment of ESRD, along with government initiatives to improve access to healthcare services, will further contribute to market growth. However, challenges such as high treatment costs, limited availability of donor organs, and complications associated with ESRD therapies may hinder market progression. Overall, the Global ESRD market is anticipated to witness a steady rise in demand for innovative treatment options and improved patient outcomes.
In the Global End Stage Renal Disease Market, Asia is expected to witness significant growth due to the increasing prevalence of chronic kidney diseases and improving healthcare infrastructure. North America remains a key market with a high prevalence of ESRD and advanced treatment options. Europe is likely to show steady growth driven by technological advancements and rising awareness about kidney diseases. The Middle East and Africa region is experiencing a growing burden of ESRD, leading to increased demand for renal replacement therapies. Latin America also presents growth opportunities, driven by improving access to healthcare services and rising investments in the healthcare sector. Overall, the global ESRD market is set to expand across all regions, with varying degrees of growth influenced by factors such as healthcare expenditure, prevalence of kidney diseases, and regulatory environment.
Global End Stage Renal Disease Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global End Stage Renal Disease Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global End Stage Renal Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Global End Stage Renal Disease Market - Industry Life Cycle |
3.4 Global End Stage Renal Disease Market - Porter's Five Forces |
3.5 Global End Stage Renal Disease Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global End Stage Renal Disease Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global End Stage Renal Disease Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.8 Global End Stage Renal Disease Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.9 Global End Stage Renal Disease Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.10 Global End Stage Renal Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global End Stage Renal Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global End Stage Renal Disease Market Trends |
6 Global End Stage Renal Disease Market, 2021 - 2031 |
6.1 Global End Stage Renal Disease Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global End Stage Renal Disease Market, Revenues & Volume, By Calcium Succinate, 2021 - 2031 |
6.1.3 Global End Stage Renal Disease Market, Revenues & Volume, By Mk-3866, 2021 - 2031 |
6.1.4 Global End Stage Renal Disease Market, Revenues & Volume, By Pacritinib, 2021 - 2031 |
6.1.5 Global End Stage Renal Disease Market, Revenues & Volume, By Sanguinate, 2021 - 2031 |
6.1.6 Global End Stage Renal Disease Market, Revenues & Volume, By Tesidolumab, 2021 - 2031 |
6.1.7 Global End Stage Renal Disease Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global End Stage Renal Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global End Stage Renal Disease Market, Revenues & Volume, By Calcimimetics, 2021 - 2031 |
6.2.3 Global End Stage Renal Disease Market, Revenues & Volume, By Vitamin D, 2021 - 2031 |
6.2.4 Global End Stage Renal Disease Market, Revenues & Volume, By Sterols, 2021 - 2031 |
6.2.5 Global End Stage Renal Disease Market, Revenues & Volume, By Potassium Binders, 2021 - 2031 |
6.2.6 Global End Stage Renal Disease Market, Revenues & Volume, By Calcium-Based, 2021 - 2031 |
6.2.7 Global End Stage Renal Disease Market, Revenues & Volume, By Phosphate Binders, 2021 - 2031 |
6.2.8 Global End Stage Renal Disease Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global End Stage Renal Disease Market, Revenues & Volume, By Indication, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global End Stage Renal Disease Market, Revenues & Volume, By End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, 2021 - 2031 |
6.3.3 Global End Stage Renal Disease Market, Revenues & Volume, By End Stage Renal Disease (ESRD) Induced Hyperkalaemia, 2021 - 2031 |
6.3.4 Global End Stage Renal Disease Market, Revenues & Volume, By End Stage Renal Disease (ESRD) Induced Hyperphosphatemia, 2021 - 2031 |
6.4 Global End Stage Renal Disease Market, Revenues & Volume, By End users, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global End Stage Renal Disease Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global End Stage Renal Disease Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.4.4 Global End Stage Renal Disease Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.4.5 Global End Stage Renal Disease Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global End Stage Renal Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global End Stage Renal Disease Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.5.3 Global End Stage Renal Disease Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.5.4 Global End Stage Renal Disease Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
7 North America End Stage Renal Disease Market, Overview & Analysis |
7.1 North America End Stage Renal Disease Market Revenues & Volume, 2021 - 2031 |
7.2 North America End Stage Renal Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
7.3 North America End Stage Renal Disease Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America End Stage Renal Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
7.5 North America End Stage Renal Disease Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.6 North America End Stage Renal Disease Market, Revenues & Volume, By End users, 2021 - 2031 |
7.7 North America End Stage Renal Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) End Stage Renal Disease Market, Overview & Analysis |
8.1 Latin America (LATAM) End Stage Renal Disease Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) End Stage Renal Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) End Stage Renal Disease Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) End Stage Renal Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
8.5 Latin America (LATAM) End Stage Renal Disease Market, Revenues & Volume, By Indication, 2021 - 2031 |
8.6 Latin America (LATAM) End Stage Renal Disease Market, Revenues & Volume, By End users, 2021 - 2031 |
8.7 Latin America (LATAM) End Stage Renal Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia End Stage Renal Disease Market, Overview & Analysis |
9.1 Asia End Stage Renal Disease Market Revenues & Volume, 2021 - 2031 |
9.2 Asia End Stage Renal Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia End Stage Renal Disease Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia End Stage Renal Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
9.5 Asia End Stage Renal Disease Market, Revenues & Volume, By Indication, 2021 - 2031 |
9.6 Asia End Stage Renal Disease Market, Revenues & Volume, By End users, 2021 - 2031 |
9.7 Asia End Stage Renal Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa End Stage Renal Disease Market, Overview & Analysis |
10.1 Africa End Stage Renal Disease Market Revenues & Volume, 2021 - 2031 |
10.2 Africa End Stage Renal Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa End Stage Renal Disease Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa End Stage Renal Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
10.5 Africa End Stage Renal Disease Market, Revenues & Volume, By Indication, 2021 - 2031 |
10.6 Africa End Stage Renal Disease Market, Revenues & Volume, By End users, 2021 - 2031 |
10.7 Africa End Stage Renal Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe End Stage Renal Disease Market, Overview & Analysis |
11.1 Europe End Stage Renal Disease Market Revenues & Volume, 2021 - 2031 |
11.2 Europe End Stage Renal Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe End Stage Renal Disease Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe End Stage Renal Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
11.5 Europe End Stage Renal Disease Market, Revenues & Volume, By Indication, 2021 - 2031 |
11.6 Europe End Stage Renal Disease Market, Revenues & Volume, By End users, 2021 - 2031 |
11.7 Europe End Stage Renal Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East End Stage Renal Disease Market, Overview & Analysis |
12.1 Middle East End Stage Renal Disease Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East End Stage Renal Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey End Stage Renal Disease Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East End Stage Renal Disease Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East End Stage Renal Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
12.5 Middle East End Stage Renal Disease Market, Revenues & Volume, By Indication, 2021 - 2031 |
12.6 Middle East End Stage Renal Disease Market, Revenues & Volume, By End users, 2021 - 2031 |
12.7 Middle East End Stage Renal Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global End Stage Renal Disease Market Key Performance Indicators |
14 Global End Stage Renal Disease Market - Export/Import By Countries Assessment |
15 Global End Stage Renal Disease Market - Opportunity Assessment |
15.1 Global End Stage Renal Disease Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global End Stage Renal Disease Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global End Stage Renal Disease Market Opportunity Assessment, By Product, 2021 & 2031F |
15.4 Global End Stage Renal Disease Market Opportunity Assessment, By Indication, 2021 & 2031F |
15.5 Global End Stage Renal Disease Market Opportunity Assessment, By End users, 2021 & 2031F |
15.6 Global End Stage Renal Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global End Stage Renal Disease Market - Competitive Landscape |
16.1 Global End Stage Renal Disease Market Revenue Share, By Companies, 2024 |
16.2 Global End Stage Renal Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |